| Nargis Z Fakhri, MD | |
|
1305 Redmond Cir Nw, Building 103 - Clinical Director's Office, Rome, GA 30165-1345 | |
| (706) 295-6285 | |
| Not Available |
| Full Name | Nargis Z Fakhri |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1305 Redmond Cir Nw, Rome, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447289244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 39568 (Georgia) | Primary |
| Entity Name | Department Of Behavioral Health And Developmental Disabilities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902030307 PECOS PAC ID: 7416002506 Enrollment ID: O20090825000435 |
News Archive
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM (cholic acid) as a once-daily treatment for cholic acid deficiency in bile acid synthesis disorders due to single enzyme defects.
A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.
Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nargis Z Fakhri, MD 1305 Redmond Cir Nw, Building 103 - Clinical Director's Office, Rome, GA 30165-1345 Ph: (706) 295-6285 | Nargis Z Fakhri, MD 1305 Redmond Cir Nw, Building 103 - Clinical Director's Office, Rome, GA 30165-1345 Ph: (706) 295-6285 |
News Archive
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM (cholic acid) as a once-daily treatment for cholic acid deficiency in bile acid synthesis disorders due to single enzyme defects.
A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.
Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 1 days ago
Dr. Erica Monique Call, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 304 Shorter Ave Nw, Rome, GA 30165 Phone: 706-232-5650 | |
Dr. Joseph K Seal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Woodbine Ave Nw, Rome, GA 30165 Phone: 706-314-0019 Fax: 706-314-0343 | |
Prima Briones, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1305 Redmond Cir Nw, Building 103 - Clinical Director's Office, Rome, GA 30165 Phone: 706-295-6285 | |
Dr. Quresh Z Bandukwala, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 314 Shorter Ave Nw, Suite100, Rome, GA 30165 Phone: 706-235-5722 Fax: 706-235-5728 | |
William K Naguszewski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 126 Three Rivers Dr Ne, Rome, GA 30161 Phone: 706-295-0070 Fax: 706-290-0520 | |
Dr. Felipe Porto De Souza Suplicy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 705 N Division St Nw, Rome, GA 30165 Phone: 808-489-1187 Fax: 352-265-3285 | |
Jeffrey Thurman Glass, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 706-233-8512 Fax: 706-233-8513 |